of 40
7/30/2019 Psychosis PDF
1/40
Early Psychosis: Early Detection,
Timely Management and Referral
Dr K H YeungMedical Officer, Department of Psychiatry, Kowloon Hospital
19 December 2010
7/30/2019 Psychosis PDF
2/40
What Is Psychosis ( )? Abnormality in
Thought: delusion
Perception: hallucination
Emotion: inappropriate affect
Behaviour: disorganised
7/30/2019 Psychosis PDF
3/40
Prevalence of Schizophrenia The lifetime risk : approximately 1% Hong Kong: about 700 cases per year Ages of onset:
Between late teens and mid 30s Men: 18 25 years Women: 25 35 years
Sex ratio:
equal
Increased prevalence in lower socioeconomic classes
Higher incidence rate for immigrants
7/30/2019 Psychosis PDF
4/40
Aetiology of Schizophrenia Genetic Developmental factors
Complications during pregnancy and birth
Born in late winter or spring: influenza infection in 2nd trimester Brain abnormalities
Ventricular enlargement Reduced brain size
Crash Course Psychiatry 2008
7/30/2019 Psychosis PDF
5/40
Aetiology of Schizophrenia Neurotransmitter abnormalities
Dopamine Glutamate 5 HT GABA
Life events More frequently in the month before a first psychotic disorder or
relapse
Expressed emotion Over involved, over critical, or hostile towards a schizophrenic pt More likely to relapse
Crash Course Psychiatry 3rd Edition 2008
7/30/2019 Psychosis PDF
6/40
Lifetime Risk of Schizophrenia
Crash Course Psychiatry 3rd edition 2008
7/30/2019 Psychosis PDF
7/40
Stahl's Essential Psychopharmacology, 3rd edition, 2008
7/30/2019 Psychosis PDF
8/40
Stahl's Essential Psychopharmacology 3rd Edition 2008
7/30/2019 Psychosis PDF
9/40
Mesolimbic Dopamine Hypothesis
Stahl's Essential Psychopharmacology 3rd Edition 2008
7/30/2019 Psychosis PDF
10/40
Stahl's Essential Psychopharmacology 3rd Edition 2008
7/30/2019 Psychosis PDF
11/40
Glutamate & Other Symptoms
Stahl's Essential Psychopharmacology 3rd Edition 2008
7/30/2019 Psychosis PDF
12/40
Amygdala
Stahl's Essential Psychopharmacology 3rd Edition 2008
7/30/2019 Psychosis PDF
13/40
Fearful Stimuli & Schizophrenia
Stahl's Essential Psychopharmacology 2008
7/30/2019 Psychosis PDF
14/40
Neutral Stimuli & Schizophrenia
Stahl's Essential Psychopharmacology 2008
7/30/2019 Psychosis PDF
15/40
Negative Symptoms
in
Prodromal
Phase
Stahl's Essential Psychopharmacology 3rd Edition 2008
7/30/2019 Psychosis PDF
16/40
Key Negative Symptoms Identified Solely on Observation
Stahl's Essential Psychopharmacology 3rd Edition 2008
7/30/2019 Psychosis PDF
17/40
Key Negative Symptoms Identified with some Questioning
Stahl's Essential Psychopharmacology 3rd Edition 2008
7/30/2019 Psychosis PDF
18/40
Prognosis of
1
st
Episode Schizophrenia
7/30/2019 Psychosis PDF
19/40
Stages of
Schizophrenia
Stahl's Essential Psychopharmacology 3rd Edition 2008
7/30/2019 Psychosis PDF
20/40
Stages of
Psychosis
8 stages 0: Increased risk, no symptoms 1a: Mild or non specific symptoms 1b: Ultra high risk: moderate but
subthreshold symptoms 2: First episode of psychotic disorder 3a: Incomplete remission from 1st episode 3b: Recurrence or relapse of psychosis 3c: Multiple relapses
4: Severe, persistent
or
unremitting
illnessModified from McGorry et al, 2006
7/30/2019 Psychosis PDF
21/40
Ultra High
Risk
Factors
Ages: 14 to 29
At least one of the following 3 groups
Attenuated psychotic
group:
sub threshold, attenuated positive psychotic symptoms during the past year
Brief limited
intermittent
psychotic
symptoms
group:
episodes of frank psychotic symptoms for < 1 week
Alison R. Yung et al, BJPsych 2007
7/30/2019 Psychosis PDF
22/40
Ultra High
Risk
Factors
Trait and state risk factor group:
Schizotypal personality disorder
1st degree relative with a psychotic disorder
Significant functioning decrease during the previous
year
Alison R. Yung et al, BJPsych 2007
7/30/2019 Psychosis PDF
23/40
Different outcome
at
ages
of
onset
Pts with adolecent onset (ages 15 18)
Poorer outcome compared with young adult (ages 19 30)
Ballageer et al, J Am Acad Child Adolesc Psychiatry. 2005 Aug;44(8):782 9
7/30/2019 Psychosis PDF
24/40
Duration of
Untreated
Psychosis
(DUP)
DUP The difference in time between the appearance of
psychotic symptoms and the first psychiatric treatment
Longer DUP
Worse clinical features Poor treatment outcome
DUP worldwide: 27 to 322 days DUP in HK:
93 days, longer DUP in male pts
JCEP Hong Kong 2010
7/30/2019 Psychosis PDF
25/40
Duration of
Untreated
Psychosis
(DUP)
Associated with Increased duration of the acute episode (Loebel et
al, 1992; McGorry et al, 1996) Worse course and outcome (Helgason, 1990; Haas
et al, 1998) Increased risk of relapse (Crow et al, 1993) Psychosocial decline (Jones et al, 1993) Prolonged morbidity ( Wyatt et al, 1997)
Warner R, Br J Psych 2005
7/30/2019 Psychosis PDF
26/40
DUP &
Brain
Morphology
Long DUP associated with reduced densities of
the right limbic area
The right hippocampus
Penttila M, et al Schizophr Res. 2010
7/30/2019 Psychosis PDF
27/40
Reducing DUP
Singapore experience
Method Compare 2 groups of 1st episode psychosis before and
after Initiation of a programme of public education
Networking with
primary
health
care
providers
Results DUP reduced from a median of 12 to 4 months Increase self and family referrals Decrease police referrals
Conclusion Awareness campaigns targeting multiple groups with various modes of communication are effective in
influencing the DUP and patter ns of help seeking
Chong SA, et al, Soc Psychiatry Psychiatr Epidemiol 2005
7/30/2019 Psychosis PDF
28/40
Reducing DUP
Norway experience Method:
Compare 2 groups of pts with 1st episode psychosis with (N=108) and without (n=75) information campaign
(IC) from Jan 1997 to Dec 2000 to raise awareness & recognising psychosis to public, schools and GPs Results
No IC period: DUP increased up to 15 weeks More symptoms Poorer functioning
Joa I et al, Schizophr Bull 2008
7/30/2019 Psychosis PDF
29/40
Reducing DUP
Hong Kong Experience:
EASY Project
since
2001
DUP decreased from 513 days to 320 days (nearly 200 days)
Hospital Authority Hong Kong
7/30/2019 Psychosis PDF
30/40
GP Training
in
1
st
Episode Psychosis
Birmingham Experience Method:
3 inner city primary care trusts in Birmingham Intervention practices addressing GP knowledge, skills
& attitudes about 1st episode psychosis
Lester H, Birchwood M, et al Br J Gen Pract 2009
7/30/2019 Psychosis PDF
31/40
GP Training
in
1
st
Episode Psychosis
Method: Primary outcomes: Difference in the number of referrals to early
intervention services between practices Secondary outcomes: Duration of untreated psychosis (DUP) Time to recovery Use of the Mental Health Act GP consultation rate during developing illness
Lester H, Birchwood M, Br J Gen Pract 2009
7/30/2019 Psychosis PDF
32/40
GP Training
in
1
st
Episode Psychosis
Birmingham Experience
Results 110 out of 135 eligible practices (81%) recruited
Referral of young people:
179 Intervention practices: 97 Control practices: 82
Secondary outcomes: No effect
Conclusion: GP training on 1st episode psychosis is insufficient to alter referral rates to early intervention
services or reduce the duration of untreated psychosis Training facilitates access to the new specialist team for early psychosis
Lester H, Birchwood M, Br J Gen Pract. 2009
7/30/2019 Psychosis PDF
33/40
Treatment of
First
Episode
Psychosis
Good symptomatic response Lower dose of antipsychotics compared with
chronic schizophrenia
More susceptible
to
extrapyramidal
side
effect
Longer exposure to potential metabolic
complications of newer antipsychotics
Nicolas A et al, BJPsych 2010
7/30/2019 Psychosis PDF
34/40
First Generation
Antipsychotics
FGAs First Episode Relapse Max
Chrorpromazine200 mg 300 mg 1000mgHaloperidol 2 mg >4 mg 30mg/dSulpiride 400 mg 800 mg 2400mgTrifluoperazine 10 mg 15 mg 30mg/d
Side effect: Parkinson like symptoms, acute dystonia, akathisia, tardive dyskinesia, neuroleptic malignant syndrome and hyperprolactinaemia
The Maudsley Prescribing Guildelines 10th Edition 2009, Crash Course 2008
7/30/2019 Psychosis PDF
35/40
Second Generation
Antipsychotics
SGAs First Episode Relapse Max
Amisulpride 400mg 800mg 1200mg/d Risperidone 1 2mg 3 4mg 16mg/d
Olanzapine 5 mg 10 mg 20mg/dQuetiapine 150 mg 300 mg 800mg/dZiprasidone 80 mg 80 mg 160mg/d
Side Effects: metabolic syndrom, hyperprolactinaemia & agranulocytosis (Clozapine)
The Maudsley Prescribing Guidelines 10th Edition 2009
7/30/2019 Psychosis PDF
36/40
Treatment of
1
st
Episode Psychosis
The Maudsley Prescribing Guidelines 10th Edition 2009
Agree choice of antipsychotic with pt &/or carer or, if not possible: Start SGA
Titrate to minimum effective dose
Adjust dose according to response and tolerability
Assess over 68 weeks
Continue at dose established as
effective
Change drug and follow above
process. Consider use of either a SGA or a FGA Consider depot
Clozapine
effective
Not effective
Not tolerate or poor
compliance
7/30/2019 Psychosis PDF
37/40
Non pharmacological Treatment of
1st Episode Psychosis Family intervention
Psychotherapy:
Cognitive behavioural
therapy
Social intervention
Occupational therapy
7/30/2019 Psychosis PDF
38/40
Factors Associated with Dangerousness
Male gender Past history of violence Active psychotic symptoms
Paranoid plus a wish to harm others Alcohol or drug abuse
Social difficulties
7/30/2019 Psychosis PDF
39/40
Prepared by 17 y.o patient's father in 2009
7/30/2019 Psychosis PDF
40/40
Referral
HA: EASY Clinic for ages from 15 to 25
29283283 Web site: www.ha.org.hk/easy
JECP Centres for ages from 26 to 55
Private psychiatrists